NCBiotech News

Istari Oncology, a young Research Triangle Park biotechnology company started by a world-famous Duke University brain cancer team, has reported rare positive results in a Phase 1 clinical trial of its experimental treatment for glioblastoma.

North Carolina’s global precision health and gene therapy profile got a boost this week with the announcement that Swiss drug giant Roche will add $2.4 billion to the $1 billion it already invested, to buy gene testing company Foundation Medicine.

Startups, small businesses and incubators developing solutions for health security needs are invited to a U.S. Department of Health and Human Services pre-proposal Webex conference call on Friday, June 22, at First Flight Venture Center in Research Triangle Park. 

Glenmark Pharmaceuticals, an India-based global pharmaceutical company, has received its first U.S. Food and Drug Administration go-ahead to market one of its North Carolina-made drugs in the United States.

Durham-based Alcami has donated $15,000 to the Wilmington Fire Department to help fund IvyGene cancer screenings for firefighters, who face above-average risk of developing cancer.

​​​​​​​Chiesi USA of Cary and its European partner Holostem Terapie Avanzate have received Orphan Drug Designation from the U.S. Food and Drug Administration for an investigational cell-based therapy for a rare eye disease.

Small North Carolina technology firms, innovators, scientists and researchers will have the opportunity on June 21 and 22 to learn more about the U.S. Small Business Administration’s grant programs.

Moise Khayrallah, Ph.D., is a serial entrepreneur with a Midas touch. His latest startup, Durham-based Emergo Therapeutics, could be another golden opportunity after raising $12 million in venture capital this spring, mostly from North Carolina investors.

Morrisville-based Humacyte, developer of a bioengineered blood vessel, has formed a global partnership with Fresenius Medical Care, the world's largest provider of dialysis products and services, and will receive a $150 million equity investment as part of the deal.

Chimerix, a Durham-based biopharmaceutical company that’s developing novel antiviral medicines for unmet medical needs, has received Orphan Drug Designation from the U.S. Food and Drug Administration for brincidofovir, its smallpox treatment.

The United States Green Building Council has awarded Grifols’ newly built administration building the Leadership in Energy and Environmental Design (LEED) Silver certification -- the second of the company’s buildings on its Johnston County campus to receive LEED certification.

Pitt County Development Commission and partner counties and organizations are packaging an“Active Site” theme and taking it on the road, to make sure the region is on the radar of any pharmaceutical company planning an expansion or a new manufacturing facility.

Morrisville-based TyraTech is beginning to make headway in the $10 billion global market for insect and parasite controls in livestock and companion animals.

Stuart Bondurant's pioneering contribution to the state’s global life science leadership, as a co-founder of the North Carolina Biotechnology Center, is honored for all to see by a distinctive two-piece sculpture in the Center’s welcoming garden area.

Precision BioSciences, a Durham-based genome editing company, has created a new name and brand identity for its food and agriculture business: Elo Life Systems.